ReviewJournal of cancer research and clinical oncology2017

Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.

Marco Gallo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.